{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "http://fortrea.com/insights/stay-ahead-curve-how-ai-reshaping-ophthalmology-trials-every-stage#webpage",
"url": "http://fortrea.com/insights/stay-ahead-curve-how-ai-reshaping-ophthalmology-trials-every-stage",
"name": "Stay ahead of the curve: How AI is reshaping ophthalmology trials at every stage",
"description": "Explore this Fortrea white paper on the growing role of AI in ophthalmology clinical trials and its impact across the clinical development lifecycle. The white paper examines how artificial intelligence and machine learning are being applied to patient recruitment, patient identification, enrollment forecasting, site selection, protocol design, endpoint selection, disease progression modeling, and trial execution to improve efficiency and decision-making in ophthalmology research. It highlights the use of AI-driven diagnostics, ophthalmic imaging analysis, predictive analytics, and data-driven insights to support clinical trial optimization, operational performance, and more effective study design. The paper also explores how AI technologies can help address recruitment challenges, improve site performance, enhance endpoint strategies, streamline trial operations, and accelerate ophthalmology drug development through smarter, evidence-based clinical research approaches."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Stay ahead of the curve: How AI is reshaping ophthalmology trials at every stage",
"item": "http://fortrea.com/insights/stay-ahead-curve-how-ai-reshaping-ophthalmology-trials-every-stage"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "http://fortrea.com/insights/stay-ahead-curve-how-ai-reshaping-ophthalmology-trials-every-stage#whitepaper",
"mainEntityOfPage": {
"@id": "http://fortrea.com/insights/stay-ahead-curve-how-ai-reshaping-ophthalmology-trials-every-stage#webpage"
},
"headline": "AI Ophthalmology Clinical Trials: Optimizing Patient Recruitment, Site Selection, Protocol Design, Endpoint Selection, and Trial Performance | Fortrea White Paper",
"description": "Explore this Fortrea white paper on the growing role of AI in ophthalmology clinical trials and its impact across the clinical development lifecycle. The white paper examines how artificial intelligence and machine learning are being applied to patient recruitment, patient identification, enrollment forecasting, site selection, protocol design, endpoint selection, disease progression modeling, and trial execution to improve efficiency and decision-making in ophthalmology research. It highlights the use of AI-driven diagnostics, ophthalmic imaging analysis, predictive analytics, and data-driven insights to support clinical trial optimization, operational performance, and more effective study design. The paper also explores how AI technologies can help address recruitment challenges, improve site performance, enhance endpoint strategies, streamline trial operations, and accelerate ophthalmology drug development through smarter, evidence-based clinical research approaches.",
"genre": "White Paper",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2026-03/ortrea-ai-ophthalmology-clinical-trials-whitepaper.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2026-03-16",
"dateModified": "2026-03-16",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-03/fortrea-ai-ophthalmology-clinical-trials-whitepaper.pdf",
"encodingFormat": "application/pdf"
}
}
]
}